Detalles de la búsqueda
1.
Diagnosing and Treating Systemic Juvenile Idiopathic Arthritis and Adult-Onset Still's Disease as Part of the Still's Disease Continuum.
Mediterr J Rheumatol
; 35(Suppl 1): 45-57, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38756937
2.
Upadacitinib: Mechanism of action, clinical, and translational science.
Clin Transl Sci
; 17(1): e13688, 2024 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37984057
3.
New insights on multigenic autoinflammatory diseases.
Ther Adv Musculoskelet Dis
; 14: 1759720X221117880, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36081748
4.
Similar Clinical Outcomes in Patients with Systemic Juvenile Idiopathic Arthritis and Adult-Onset Still's Disease Treated with Canakinumab: Bayesian and Population Model-Based Analyses.
Rheumatol Ther
; 9(2): 753-762, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35044647
5.
Reasons for Initiating Canakinumab among Patients with Systemic Juvenile Idiopathic Arthritis and Adult-Onset Still's Disease in the U.S. Real-World Settings.
Rheumatol Ther
; 9(1): 265-283, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34874547
6.
Adult-onset Still's disease in focus: Clinical manifestations, diagnosis, treatment, and unmet needs in the era of targeted therapies.
Semin Arthritis Rheum
; 51(4): 858-874, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34175791
7.
Articular and Extra-Articular Benefits in ACR20 Non-responders at Week 104 Treated With Apremilast: Pooled Analysis of Three Randomized Controlled Trials.
Rheumatol Ther
; 8(4): 1677-1691, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34536218
Resultados
1 -
7
de 7
1
Próxima >
>>